ABBV - AbbVie inks licensing pact for bowel disorder therapy
2024-06-13 08:25:53 ET
More on AbbVie
- AbbVie, Inc. (ABBV) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
- AbbVie: Turnaround Lurking After The Correction Pain (Upgrade)
- AbbVie: This Dividend Aristocrat Is Almost Buyable Again Now
- Cerevel Therapeutics gains after AbbVie says making good progress with FTC
- AbbVie-partnered therapy selected for FDA’s rare disease pilot program